FindTrial
Sign In

Application and evaluation of Chinese medicine treatment plan in influenza

Application and evaluation of Chinese medicine treatment plan in influenza

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2000002919
Enrollment
Unknown
Registered
2020-01-14
Start date
2020-01-07
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza

Interventions

western medicine treatment group:western medicine treatment plan
Chinese medicine treatment group:Chinese medicine treatment plan
integrated Chinese and western medicine treatment group:integrated Chinese and western medicine treatment plan

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. All adults (age >= 18 years) who meet the above clinical diagnosis of influenza and determine the criteria for diagnosis are included in the study observation. 2. Get the patient's information, volunteer to sign and sign the informed consent.

Exclusion criteria

Exclusion criteria: Severe flu patients.

Design outcomes

Primary

MeasureTime frame
The incidence of complications;Negative rate of influenza virus detection;Time to disappear of main symptoms;Incidence of severe illness;—

Secondary

MeasureTime frame
Antipyretic time;—

Countries

China

Contacts

Public ContactZhang Zhongde

Guangdong Provincial Hospital of Chinese Medicine

doctorzzd99@163.com+86 18602010082

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026